Intensive glycemic control has no impact on the risk of heart failure in type 2 diabetic patients: Evidence from a 37,229 patient meta-analysis

American Heart Journal

Volumn 162, Issue 5, 2011, Pages

  Castagno, Davide ^a,b   Baird Gunning, Jonathan ^b   Jhund, Pardeep S ^b   Biondi Zoccai, Giuseppe ^a   MacDonald, Michael R ^c   Petrie, Mark C ^c   Gaita, Fiorenzo ^a   McMurray, John J V ^b  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c GOLDEN JUBILEE NATIONAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ACARBOSE; ALPHA GLUCOSIDASE INHIBITOR; CHLORPROPAMIDE; GLIBENCLAMIDE; GLICLAZIDE; GLIMEPIRIDE PLUS ROSIGLITAZONE; GLIPIZIDE; GLITAZONE DERIVATIVE; HEMOGLOBIN A1C; INCRETIN; INSULIN; METFORMIN; METFORMIN PLUS ROSIGLITAZONE; PIOGLITAZONE; PLACEBO; ROSIGLITAZONE; SULFONYLUREA;

ARTICLE; CARDIOVASCULAR RISK; CINAHL; COCHRANE LIBRARY; DIABETIC PATIENT; DOSAGE SCHEDULE COMPARISON; FOLLOW UP; GLYCEMIC CONTROL; HEART FAILURE; HEMOGLOBIN BLOOD LEVEL; HUMAN; MEDLINE; META ANALYSIS; MULTICENTER STUDY (TOPIC); NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW;

EID: 81255185326     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2011.07.030     Document Type: Article

References (40)

1. W.B. Kannel, M. Hjortland, and W.P. Castelli Role of diabetes in congestive heart failure: the Framingham study Am J Cardiol 34 1974 29 34
2. J.S. Gottdiener, A.M. Arnold, and G.P. Aurigemma Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study J Am Coll Cardiol 35 2000 1628 1637 (Pubitemid 30307510)
3. J. He, L.G. Ogden, and L.A. Bazzano Risk factors for congestive heart failure in US men and women: NHANES-I epidemiologic follow-up study Arch Intern Med 161 2001 996 1002 (Pubitemid 32295654)
4. C. Iribarren, A.J. Karter, and A.S. Go Glycemic control and heart failure among adult patients with diabetes Circulation 103 2001 2668 2673 (Pubitemid 32538780)
5. G.A. Nichols, C.M. Gullion, and C.E. Koro The incidence of congestive heart failure in type 2 diabetes: an update Diabetes Care 27 2004 1879 1884 (Pubitemid 38989226)
6. I.S. Thrainsdottir, T. Aspelund, and G. Thorgeirsson The association between glucose abnormalities and heart failure in the population-based Reykjavik study Diabetes Care 28 2005 612 616 (Pubitemid 40315321)
7. I.M. Stratton, A.I. Adler, H.A. Neil on behalf of the UK Prospective Diabetes Study Group Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study BMJ 321 2000 405 412 (Pubitemid 30609442)
8. UK Prospective Diabetes Study (UKPDS) Group Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) Lancet 352 1998 837 853
9. UK Prospective Diabetes Study (UKPDS) Group Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) Lancet 352 1998 854 865
10. Action to Control Cardiovascular Risk in Diabetes Study Group Effects of intensive glucose lowering in type 2 diabetes N Engl J Med 358 2008 2545 2559
11. ADVANCE Collaborative Group Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes N Engl J Med 358 2008 2560 2572
12. W. Duckworth, C. Abraira, and T. Moritz Glucose control and vascular complications in veterans with type 2 diabetes N Engl J Med 360 2009 129 139
13. R.M. Lago, P.P. Singh, and R.W. Nesto Congestive heart failure and cardiovascular death in patients with prediabetes and type 2 diabetes given thiazolidinediones: a meta-analysis of randomised clinical trials Lancet 370 2007 1129 1136 (Pubitemid 47464583)
14. V.A. Koivisto Insulin therapy in type II diabetes Diabetes Care 3 1993 29 39 (Pubitemid 23348319)
15. K.A. Robinson, and K. Dickersin Development of a highly sensitive search strategy for the retrieval of reports of controlled trials using PubMed Int J Epidemiol 31 2002 150 153 (Pubitemid 34284917)
16. The University Group Diabetes Program A study of the effect of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. V. Evaluation of pheniformin therapy Diabetes 24 suppl 1 1975 65 184
17. The University Group Diabetes Program Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. VIII. Evaluation of insulin therapy: final report Diabetes 31 suppl 5 1982 1 81
18. J.L. Chiasson, R.G. Josse, R. Gomis STOP-NIDDM Trial Research Group Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial JAMA 290 2003 486 494 (Pubitemid 37430502)
19. DREAM (Diabetes REduction Assessment with ramipril and rosiglitazone Medication) Trial Investigators, Gerstein H.C., and Yusuf S. Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial Lancet 368 2006 1096 1105
20. M. Shichiri, H. Kishikawa, and Y. Ohkubo Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetes patients Diabetes Care 23 Suppl 2 2000 B21 B29
21. P. Gaede, H. Lund-Andersen, and H.H. Parving Effect of a multifactorial intervention on mortality in type 2 diabetes N Engl J Med 358 2008 580 591 (Pubitemid 351214285)
22. S.E. Kahn, S.M. Haffner, M.A. Heise ADOPT Study Group Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy N Engl J Med 355 2006 2427 2443 (Pubitemid 44903747)
23. Malmberg K., Rydén L., and Wedel H. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity Eur Heart J 26 2005 650 661 (Pubitemid 40516876)
24. I. Raz, P.W. Wilson, and K. Strojek Effects of prandial versus fasting glycemia on cardiovascular outcomes in type 2 diabetes: the HEART2D trial Diabetes Care 32 2009 381 386
25. BARI 2D Study Group R.L. Frye, and P. August A randomized trial of therapies for type 2 diabetes and coronary artery disease N Engl J Med 360 2009 2503 2515
26. C. Abraira, J. Colwell, and F. Nuttall Cardiovascular events and correlates in the Veterans Affairs Diabetes Feasibility Trial. Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type II Diabetes Arch Intern Med 157 1997 181 188 (Pubitemid 27058152)
27. Dormandy J.A., Charbonnel B., and Eckland D.J. PROactive investigators. Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial Lancet 366 2005 1279 1289 (Pubitemid 41416583)
28. P.D. Home, S.J. Pocock, and H. Beck-Nielsen Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial Lancet 373 2009 2125 2135
29. C. Held, H.C. Gerstein, and S. Yusuf Glucose levels predict hospitalization for congestive heart failure in patients at high cardiovascular risk Circulation 115 2007 1371 1375 (Pubitemid 46648372)
30. C.J. Currie, J.R. Peters, and A. Tynan Survival as a function of HbA(1c) in people with type 2 diabetes: a retrospective cohort study Lancet 375 2010 481 489
31. S. Zoungas, A. Patel, J. Chalmers ADVANCE Collaborative Group Severe hypoglycemia and risks of vascular events and death N Engl J Med 363 2010 1410 1418
32. S. Boudina, and D.E. Abel Diabetic cardiomyopathy revisited Circulation 115 2007 3213 3223 (Pubitemid 47012236)
33. A.A. Carr, P.R. Kowey, and R.B. Devereux Hospitalizations for new heart failure among subjects with diabetes mellitus in the RENAAL and LIFE studies Am J Cardiol 96 2005 1530 1536 (Pubitemid 41690173)
34. D.M. Lloyd-Jones, M.G. Larson, and E.P. Leip Lifetime risk for developing congestive heart failure: the Framingham Heart Study Circulation 106 2002 3068 3072 (Pubitemid 35440290)
35. R.R. Holman, S.K. Paul, and M.A. Bethel 10-year follow-up of intensive glucose control in type 2 diabetes N Engl J Med 359 2008 1577 1589
36. M. Komajda, J.J. McMurray, and H. Beck-Nielsen Heart failure events with rosiglitazone in type 2 diabetes: data from the RECORD clinical trial Eur Heart J 31 2010 824 831
37. E. Mannucci, M. Monami, and C. Lamanna Prevention of cardiovascular disease trough glycemic control in type 2 diabetes: a meta-analysis of randomized clinical trials Nutr Metab Cardiovasc Dis 19 2009 604 612
38. K.K. Ray, S.R. Seshasai, and S. Wijesuriya Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials Lancet 373 2009 1765 1772
39. Control Group F.M. Turnbull, and C. Abraira Intensive glucose control and macrovascular outcomes in type 2 diabetes Diabetologia 52 2009 2288 2298
40. T.N. Kelly, L.A. Bazzano, and V.A. Fonseca Systematic review: glucose control and cardiovascular disease in type 2 diabetes Ann Intern Med 151 2009 394 403